Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.1.3.9 - glucose-6-phosphatase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acidosis
Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation.
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
[Stimulation of gluconeogenic capacity in partially hepatectomized rats (author's transl)]
Acidosis, Lactic
An algorithmic approach to diagnosis of hypoglycemia.
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Hypovitaminosis D in glycogen storage disease type I.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Problems in the congenital lactic acidoses.
[Neutropenia in glycogenesis I B]
Acute Kidney Injury
[Activity of glycolysis key enzymes in subcellular structures of normal kidneys and under acute renal insufficiency]
Adenocarcinoma
Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
Adenocarcinoma of Lung
Establishment and characteristics of a human lung adenocarcinoma cell line.
Adenoma
A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported.
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Development of liver tumors in transforming growth factor alpha transgenic mice.
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Orthotopic liver transplantation in glucose-6-phosphatase deficiency--Von Gierke disease--with multiple hepatic adenomas and concomitant focal nodular hyperplasia.
Adenoma, Bile Duct
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Adenoma, Liver Cell
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes.
Adrenoleukodystrophy
Metabolic disorders in children.
Alopecia
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Alzheimer Disease
Caffeoylquinic acids with potential biological activity from plant in vitro cultures as alternative sources of valuable natural products.
Anaphylaxis
Morphochemical investigations of the liver and biochemical studies of the blood of guinea pigs in anaphylactic shock.
Anemia, Hemolytic
Acute haemolytic anaemia in glucose-6-phosphatase dehydrogenase deficient children.
Asbestosis
Biochemical mechanisms in asbestos toxicity.
Ataxia
Lack of coordination between glucose-6-phosphatase and gamma glutamyltranspeptidase activities in rat hepatocytes maintained in primary culture.
Bacterial Infections
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
Brain Ischemia
Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia.
Breast Neoplasms
Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
Carcinogenesis
Changes in the activities of glucose-6-phosphatase, aldolase, and alkaline phosphatase during azo-dye carcinogenesis.
Cytochemical localization and biochemical analysis of the enzyme markers in human hepatoma cell lines.
Cytoplasmic changes in level and distribution of glucose-6-phosphatase activities from rat liver during diethylnitrosamine-induced carcinogenesis.
Demonstration of glucose 6-phosphatase activity in the oval cells of rat liver and the significance of the oval cells in azo dye carcinogenesis.
Enzyme pattern and growth rate of liver preneoplastic clones during carcinogenesis by diethylnitrosamine.
Glucose-6-phosphatase activity in rat liver parenchyma during azo-dye carcinogenesis.
Histochemical studies of glucose-6-phosphatase activity in the early proliferative stage of liver carcinogenesis.
Nucleolar succinate dehydrogenase & glucose-6-phosphatase activities during hepatocellular carcinogenesis in thioacetamide fed rat.
[Comparative study of glucose-6-phosphatase loss and serologic specificity in rat liver cells during incipient carcinogenesis]
[Glucose-6-phosphatase activity and the effect on this activity of some inductors at different stages of liver carcinogenesis]
[Glucose-6-phosphatase activity in liver carcinogenesis and in transplantable murine hepatomas]
Carcinoma
Carbohydrate metabolism in human renal clear cell carcinomas.
Correlative histochemical studies on preneoplastic and neoplastic lesions in the kidney of rats treated with nitrosamines.
Development of liver tumors in transforming growth factor alpha transgenic mice.
Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B.
Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
[Behavior of glucose-6-phosphatase & acid & alkaline phosphatases in the Ehrlich solid carcinoma.]
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
[Submicroscopic localization of glucose-6-phosphatase in leukoplakia and carcinoma of the oral cavity]
Carcinoma, Ehrlich Tumor
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Carcinoma, Hepatocellular
A case of minimal deviation hepatoma in man with elevated liver-type pyruvate kinase isozyme.
A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin.
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures.
Adiponectin represses gluconeogenesis independent of insulin in hepatocytes.
Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade.
An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes.
Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/forkhead box class O1-dependent pathway in hepatocytes.
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a).
Changes in the glucose-6-phosphatase complex in hepatomas.
Cloning and sequencing of the 5' region of the human glucose-6-phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells.
Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line.
Construction and characterization of a conditionally active construct of the insulin-regulated forkhead transcription factor FKHR.
Correlation between growth rate and cytochemistry in Morris hepatomas.
Coupling of glucose response element from L-type pyruvate kinase and G6Pase promoter enhances glucose responsive activity in hepatoma cells.
Cytochemical localization and biochemical analysis of the enzyme markers in human hepatoma cell lines.
Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells.
Distribution of glucose-6-phosphatase activity in normal, hyperplastic, and preneoplastic rat liver.
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
Effect of insulin on the induction by dexamethasone of glucose-6-phosphohydrolase and translocase activities in cultured hepatoma cells.
Effect of Morris 7777 hepatoma on microsomal glucose-6-phosphatase latent activity.
Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells.
Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Enhanced Trimethylation of Histone H3 Mediates Impaired Expression of Hepatic Glucose 6-Phosphatase Expression in Offspring From Rat Dams Exposed to Hypoxia During Pregnancy.
Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
Enzyme histochemical phenotypes in primary hepatocellular carcinomas.
Evaluation of the antidiabetic potential of Psidium guajava L. (Myrtaceae) using assays for ?-glucosidase, ?-amylase, muscle glucose uptake, liver glucose production, and triglyceride accumulation in adipocytes.
Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors.
FACTORS INFLUENCING GLUCOSE-6-PHOSPHATASE ACTIVITY IN THE LIVER IN TRANSPLANTABLE CHRYSOIDIN HEPATOMA IN MICE.
Glucose-6-phosphatase activity in regenerating cholangiole cells and hepatoma cells.
Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
HISTOCHEMICAL DEMONSTRATION OF GLUCOSE-6-PHOSPHATASE IN TRANSPLANTABLE CHRYSOIDIN-INDUCED HEPATOMA.
Hypoglycemic effects of brassinosteroid in diet-induced obese mice.
Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells.
Importance of Hepatocyte Nuclear Factor 4? in Glycerol-induced Glucose-6-phosphatase Expression in Liver.
Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro.
Induction of glucose 6-phosphatase in cultured hepatoma cells by dexamethasone.
Inhibition of Glycogen Synthase Kinase-3? by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica).
Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms.
Intestinal glucose-dependent expression of glucose-6-phosphatase: involvement of the aryl receptor nuclear translocator transcription factor.
Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP.
Lead (Pb) exposure promotes diabetes in obese rodents.
Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.
Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.
Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells.
Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma.
Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
Phenolic Diterpenes from Rosemary Suppress cAMP Responsiveness of Gluconeogenic Gene Promoters.
Phorbol ester-induced activation of mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase and extracellular-signal-regulated protein kinase decreases glucose-6-phosphatase gene expression.
Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha.
Potential markers (enzymes, proteoglycans) for human liver tumors.
Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine.
Regulation of glucose-6-phosphatase gene expression by insulin and metformin.
Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.
Rev-erb? activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo.
Some peculiar biological and biochemical properties of a mouse hepatoma induced by chrysoidin. III. Activity of glucose-6-phosphatase.
Structural constraints and importance of caffeic acid moiety for anti-hyperglycemic effects of caffeoylquinic acids from chicory.
The comparative enzymology and cell origin of rat hepatomas. II. Glutamate dehydrogenase, choline oxidase, and glucose-6-phosphatase.
The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements.
The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis.
The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
Thioacetamide-induced hepatocarcinoma in rat.
Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
Ultracytochemical localization of glucose-6-phosphatase in Chang rat hepatoma in vivo and in vitro.
Use of protein-mediated lipid exchange in the study of membrane-bound enzymes. The lipid dependence of glucose-6-phosphatase.
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
[Change in the structure of glucose-6-phosphatase in Zajdela ascitic hepatoma cells]
[FDG-PET in hepatocellular carcinoma. Based on one case]
[Glucose-6-phosphatase activity in liver carcinogenesis and in transplantable murine hepatomas]
[Noradrenaline and glycogen content and the activity of several enzymes of carbohydrate metabolism in normal, embryonic, and partly denervated livers and in hepatomas of the rat]
[Photodynamic action of hypocrellin A on hepatoma cell mitochondria and microsomes]
[Study of lipid dependence of glucose-6-phosphatase from rat liver and hepatoma using lipid exchange proteins]
Carcinoma, Renal Cell
Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B.
Carcinoma, Squamous Cell
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Cardiotoxicity
Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.
Chemical and Drug Induced Liver Injury
[Effect of Arnica montana tincture on some hydrolytic enzyme activities of rat liver in experimental toxic hepatitis]
[Phosphatidylcholine-induced repair of damaged hepatocyte membranes in heliotrine poisoning]
Cholecystitis
Liver involvement in cholecystitis and in obstructive icterus. A study with special reference to hexobarbital metabolism and glucose-6-phosphatase activity of human liver microsomes.
Cholestasis
Evaluation of key gluconeogenic enzymes in experimental biliary obstruction.
Liver metabolic zonation in rat biliary cirrhosis: distribution is reverse of that in toxic cirrhosis.
Choriocarcinoma
The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation.
Coccidiosis
[Synthesis of glucose-6-phosphatase in small intestine mucosa during experimental coccidiosis in suckling piglets]
Conjunctivitis
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Crohn Disease
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Cysts
Some enzymes of gluconeogenesis in various fractions of sarcocysts of Sarcocystis fusiformis of buffalo (Bubalus bubalis).
[Submicroscopic localization of glucose-6-phosphatase in the walls of dental cysts]
Dementia
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia.
Diabetes Mellitus
Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level.
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice.
Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release.
Investigation of repressive and enhancive effects of fruit extracts on the activity of glucose-6-phophatase.
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
Phenolic Diterpenes from Rosemary Suppress cAMP Responsiveness of Gluconeogenic Gene Promoters.
The glucose-6-phosphatase system in human development.
Diabetes Mellitus, Experimental
Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase.
Hormonal factors affecting glucose 6-phosphatase activity. 2. Some effects of diet and of alloxan diabetes in the rat.
[Behavior of renal glucose-6-phosphatase in experimental alloxan diabetes in rats]
[On the appearance of glucose-6-phosphatase in the pancreas of the white rat during alloxan diabetes]
Diabetes Mellitus, Type 1
A SNP in G6PC2 predicts insulin secretion in type 1 diabetes.
Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas.
Autoantigen Recognition Is Required for Recruitment of IGRP206-214-Autoreactive CD8+ T Cells but Is Dispensable for Tolerance.
DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1.
Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.
Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype.
Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.
Genetic Variability of GCKR Alters Lipid Profiles in Children with Monogenic and Autoimmune Diabetes.
Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells.
Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein-Reactive CD4+ T Cells in Human Subjects.
Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo.
Modeling competition among autoreactive CD8+ T cells in autoimmune diabetes: implications for antigen-specific therapy.
Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells.
Diabetes Mellitus, Type 2
A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.
A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin.
Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.
Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes.
G6PC2 Modulates Fasting Blood Glucose In Male Mice in Response to Stress.
Gene-gene interactions lead to higher risk for development of type 2 diabetes in a Chinese Han population: a prospective nested case-control study.
Glucose-6-Phosphatase and ?-Glucosidase Inhibitors from Smilax moranensis Roots Identified by Affinity-Directed Fractionation.
Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes.
Glucotoxicity Induces Glucose-6-Phosphatase Catalytic Unit Expression by Acting on the Interaction of Hypoxia Inducible Factor-1? With cAMP-Responsive Element-Binding Protein-Binding Protein.
Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.
Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.
Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein.
Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes.
Mutation/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients.
New In Vitro Studies on the Bioprofile of Genista tenera Antihyperglycemic Extract.
Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
STAT3 targets the regulatory regions of gluconeogenic genes in vivo.
Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection.
The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase.
The beta cell in NIDDM: giving light to the blind.
The flavonoid silibinin decreases glucose-6-phosphate hydrolysis in perfused rat hepatocytes by an inhibitory effect on glucose-6-phosphatase.
The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects.
Transcriptional regulation of glucose-6-phosphatase catalytic subunit promoter by insulin and glucose in the carnivorous fish, Sparus aurata.
Von Gierke's disease adopts an orphan (and its partner).
[The role of arecoline on hepatic insulin resistance in type 2 diabetes rats].
Diabetic Nephropathies
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
dipeptidyl-peptidase iv deficiency
Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes.
Diverticulum
Identification, expression and regulation of amphioxus G6Pase gene with an emphasis on origin of liver.
Dyslipidemias
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase.
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Endometrial Neoplasms
Therapeutic potential of riboflavin, niacin and ascorbic Acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
Fabry Disease
Rapid molecular diagnosis of genetic diseases by high resolution melting analysis: fabry and glycogen storage 1A diseases.
Fanconi Syndrome
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
[The Fanconi-Bickel syndrome]
Fatty Liver
Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
Fetal Growth Retardation
Enhanced Trimethylation of Histone H3 Mediates Impaired Expression of Hepatic Glucose 6-Phosphatase Expression in Offspring From Rat Dams Exposed to Hypoxia During Pregnancy.
Fructose-1,6-diphosphatase and glucose-6-phosphatase in newborn rats with intrauterine growth retardation.
Placenta of idiopathic fetal growth restriction: cytochemically detectable enzyme activities do not change at a subcellular level.
[Effect of intrauterine growth retardation on gluconeogenic enzymes in rat liver].
Focal Nodular Hyperplasia
Orthotopic liver transplantation in glucose-6-phosphatase deficiency--Von Gierke disease--with multiple hepatic adenomas and concomitant focal nodular hyperplasia.
Potential markers (enzymes, proteoglycans) for human liver tumors.
Fructose Intolerance
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Gallstones
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.
Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones.
Genetic Diseases, Inborn
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
Cell death and stress signaling in glycogen storage disease type I.
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
[Biological and physiopathological aspects of hepatic glycogenoses]
Glioblastoma
Glucose-6-phosphatase is a Key Metabolic Regulator of Glioblastoma Invasion.
Glucose Intolerance
18?-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism.
A high-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice.
Comparative Effects of the Renin-Angiotensin System Blockers on Nonalcoholic Fatty Liver Disease and Insulin Resistance in C57Bl/6 Mice.
Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure.
Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production.
Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.
Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.
Hepatic overexpression of dominant negative Mlx improves metabolic profile in diabetes-prone C57BL/6J mice.
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.
Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
The Impact of Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on Glycemia.
Up-regulation of liver glucose-6-phosphatase in rats fed with a P(i)-deficient diet.
Glucose Metabolism Disorders
A new mechanism of POCD caused by sevoflurane in mice: cognitive impairment induced by cross-dysfunction of iron and glucose metabolism.
glucose-6-phosphatase deficiency
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
An algorithmic approach to diagnosis of hypoglycemia.
Analysis of the albino-locus region of the mouse: IV. Characterization of 34 deficiencies.
Candidate polymorphisms and severe malaria in a malian population.
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy.
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
Defect of platelet function associated with chronic hypoglycaemia.
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
Disorders associated with purine and pyrimidine metabolism.
FDG PET/CT in Type I Glycogen Storage Disease.
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
Generation of mice with a conditional allele for G6pc.
Glucose 6-phosphatase deficiency: mechanisms of genetic control and biochemistry.
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
Glucose-6-phosphatase deficiency and hyperlipaemia.
Glucose-6-phosphatase deficiency caused by radiation-induced alleles at the albino locus in the mouse.
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
Glucose-6-phosphatase deficiency.
Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells.
Glycogenosis type IB: possible membrane transport defect.
Hepatic adenomata with type 1 glycogen storage disease.
Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome.
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Human microsomal glucose-6-phosphatase system.
Hydropericardium causing sudden infant death in glycogenosis type I: osmotic injury due to percutaneous silastic catheterization.
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
Impaired platelet function in glucose-6-phosphatase deficiency.
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
Learning from claims: hyperbilirubinaemia and kernicterus.
Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
The gene for glycogen-storage disease type 1b maps to chromosome 11q23.
The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice.
The lactate concentration of the urine, a parameter for the adequacy of dietary treatment of patients with glucose-6-phosphatase deficiency.
The molecular basis of the type 1 glycogen storage diseases.
The molecular basis of type 1 glycogen storage diseases.
The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy.
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Urate production in heterozygotes for glucose-6-phosphatase deficiency.
[A case of Gierke's disease]
[Definition and classification of hyperuricemia]
[Late manifestation of glycogenosis I in early adulthood]
[Late manifestations of glycogenosis 1 in early adulthood]
[Treatment of glycogen storage diseases]
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
Glucosephosphate Dehydrogenase Deficiency
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
glycerol-3-phosphate dehydrogenase deficiency
The beta cell in NIDDM: giving light to the blind.
Glycogen Storage Disease
11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
3'-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and Glycogen Storage Disease type-Ia risk.
A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported.
A case of type Ia glycogen storage disease complicated by hepatic adenoma.
A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.
A common 2 bp deletion mutation in the glucose-6-phosphatase gene in Indian patients with glycogen storage disease type Ia.
A conformational model for the human liver microsomal glucose-6-phosphatase system: evidence from rapid kinetics and defects in glycogen storage disease type 1.
A detailed characterization of the adult mouse model of glycogen storage disease Ia.
A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia.
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system.
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
A new variant of glycogen storage disease type 1: probably due to a defect in the glucose-6-phosphate transport system.
A novel DraI polymorphism in the 3' untranslated region of human glucose-6-phosphatase gene: useful for carrier detection and prenatal diagnosis of glycogen storage disease type 1a.
A novel mutation in the glucose-6-phosphatase gene in Korean twins with glycogen storage disease type Ia.
A novel type heterozygous mutation in the glucose-6-phosphatase gene in a Chinese patient with glycogen storage disease Ia.
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
AAV-MEDIATED CORRECTION OF A CANINE MODEL OF GLYCOGEN STORAGE DISEASE TYPE IA.
Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a.
Acoustic accessibility investigation for ultrasound mediated treatment of glycogen storage disease type ia patients.
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats.
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase.
Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.
Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.
Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia).
Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia.
Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
Cell death and stress signaling in glycogen storage disease type I.
Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab.
Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
Clinical and enzymological studies in a child with type I glycogen storage disease associated with partial deficiency of hepatic glucose-6-phosphatase.
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy.
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
Continuous glucose monitoring in children with glycogen storage disease type I.
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors.
Demonstration of a metabolically active glucose-6-phosphate pool in the lumen of liver microsomal vesicles.
Dietary management of Type I glycogen storage disease.
Disturbed lipid metabolism in glycogen storage disease type 1.
Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Iotaa.
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Emerging therapies for glycogen storage disease type I.
Exercise capacity and biochemical profile during exercise in patients with glycogen storage disease type I.
Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan.
FDG PET/CT in Type I Glycogen Storage Disease.
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
Gene therapy for type I glycogen storage diseases.
Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a.
Genetic analysis of the glucose-6-phosphatase mutation of type 1a glycogen storage disease in a Chinese family.
Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus.
Genetic evidence for the common identity of glucose-6-phosphatase, pyrophosphate-glucose phosphotransferase, carbamyl phosphate-glucose phosphotransferase and inorganic pyrophosphatase.
Glucose 6-phosphate transport in fibroblast microsomes from glycogen storage disease type 1b patients: evidence for multiple glucose 6-phosphate transport systems.
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
Glucose-6-phosphatase and type 1 glycogen storage disease: some critical considerations.
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
Glucose-6-phosphatase deficiency.
Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse.
Glucose-6-phosphatase gene (727G-->T) splicing mutation is prevalent in Hong Kong Chinese patients with glycogen storage disease type 1a.
Glucose-6-phosphatase gene G327A mutation is common in Chinese patients with glycogen storage disease type Ia.
Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
Glucose-6-phosphatase gene mutations in Taiwan Chinese patients with glycogen storage disease type Ia.
Glucose-6-phosphatase gene mutations in Turkish patients with glycogen storage disease type Ia.
GLUCOSE-6-PHOSPHATASE IN HUMAN JEJUNAL MUCOSA. LACK OF ACTIVITY IN GLYCOGENOSIS OF CORI'S TYPE 1.
Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype.
Glucose-6-phosphatase of the liver in glycogen storage disease.
Glycogen storage disease diagnosed in adults.
Glycogen storage disease of the liver; report of an atypical case with studies of the glycogen structure and the glucose-6-phosphatase activity of the liver.
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies.
Glycogen storage disease type 1a in three siblings with the G270V mutation.
Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
Glycogen storage disease type 1b due to a defect of glucose-6-phosphate translocase.
Glycogen storage disease type 1b: microsomal glucose-6-phosphatase system in two patients with different clinical findings.
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
Glycogen storage disease type I: laboratory data and diagnosis.
Glycogen storage disease type Ia (GSD Ia) during pregnancy: report of a case complicated by fetal growth restriction and preeclampsia.
Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability.
Glycogen storage disease type Ia: four novel mutations (175delGG, R170X, G266V and V338F) identified. Mutations in brief no. 220. Online.
Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells.
Glycogen storage disease type Ia: molecular study in Brazilian patients.
Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart.
Glycogen storage disease type Ib without neutropenia.
Gouty tendinitis revealing glycogen storage disease Type Ia in two adolescents.
Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia.
Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector.
Heteroduplex analysis: a useful screening method for glycogen storage disease type Ia.
Heterogeneous mutations in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia.
Historical highlights and unsolved problems in glycogen storage disease type 1.
Human microsomal glucose-6-phosphatase system.
Human variant glucose-6-phosphate transporter is active in microsomal transport.
Hydropericardium causing sudden infant death in glycogenosis type I: osmotic injury due to percutaneous silastic catheterization.
Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
Hypovitaminosis D in glycogen storage disease type I.
Identification of a novel missense mutation (T16A) in the glucose-6-phosphatase gene in a Taiwan Chinese patient with glycogen storage disease Ia (Von Gierke disease).
Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes.
Identification of a point mutation (G727T) in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type 1a, and carrier screening in healthy volunteers.
Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.
Identification of mutations in the glucose-6-phosphatase gene in Czech and Slovak patients with glycogen storage disease type ia, including novel mutations K76N, V166A and 540del5.
Identification of the human hepatic microsomal glucose-6-phosphatase enzyme.
Identification of three novel mutations (Q54P, W70X and T108I) in the glucose-6-phosphatase gene of patients with glycogen storage disease type Ia. Mutation in brief no. 256. Online.
Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
In vivo evidence for defective activity of glucose-6-phosphatase in type IB glycogenosis.
In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a.
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.
Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.
Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia.
Infectious and bleeding complications in patients with glycogenosis Ib.
Intestinal function in glycogen storage disease type I.
Intestinal glucose-6-phosphatase in control subjects and relatives of a patient with glycogen storage disease.
Investigation of repressive and enhancive effects of fruit extracts on the activity of glucose-6-phophatase.
Is glycogen storage disease 1a associated with atherosclerosis?
Ischemic stroke in an adult with glycogen storage disease type I.
Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia.
Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A.
Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children.
Liver and liver cell transplantation for glycogen storage disease type IA.
Liver transplantation in glycogen storage disease type I.
Liver-specific glucose-6-phosphatase is not present in human placenta.
Living donor liver transplantation for glycogen storage disease type Ib.
Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer.
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia.
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6-phosphatase gene.
Molecular diagnosis of type 1c glycogen storage disease.
Molecular genetic analysis of glycogen storage disease type Ia in 26 Chinese patients.
Molecular genetics of type 1 glycogen storage disease.
Molecular Genetics of Type 1 Glycogen Storage Diseases.
Molecular pathology of glucose-6-phosphatase.
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis.
Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia.
Mutational spectrum and identification of five novel mutations in G6PC1 gene from a cohort of Glycogen Storage Disease Type 1a.
Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c.
Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia.
Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a.
Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.
NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia.
New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Ontogeny of the murine glucose-6-phosphatase system.
Oral manifestations in glycogen storage disease type 1b.
Oxidative stress mediates nephropathy in type Ia glycogen storage disease.
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Possibilities for the cytochemical diagnosis of enzymopathies.
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Preemptive liver-kidney transplantation in von Gierke disease: a case report.
Prenatal diagnosis in a Chinese family with type Ia glycogen storage disease by PCR-based genetic analysis.
Prenatal diagnosis of glycogen storage disease type 1a by single stranded conformation polymorphism (SSCP).
Prenatal diagnosis of glycogen storage disease type Ia by restriction enzyme digestion.
Prenatal diagnosis of glycogen storage disease type Ia, presenting a new mutation in the glucose-6-phosphatase gene.
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib.
Rapid height growth after liver transplantation in adulthood.
Rapid molecular diagnosis of genetic diseases by high resolution melting analysis: fabry and glycogen storage 1A diseases.
Rapid screening of 12 common mutations in Turkish GSD 1a patients using electronic DNA microarray.
Renal complications in glycogen storage disease type I.
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Simultaneous liver-kidney transplantation for glycogen storage disease type IA (von Gierke's disease).
Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings.
Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a.
STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.
Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro.
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
The carbohydrate response element binding protein (ChREBP) and not the liver X receptor ? (LXR?) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
The glucose-6-phosphatase system in human development.
The glucose-6-phosphatase system.
The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein.
The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase.
The molecular basis of the genetic deficiencies of five of the components of the glucose-6-phosphatase system: improved diagnosis.
The molecular basis of the type 1 glycogen storage diseases.
The molecular basis of type 1 glycogen storage diseases.
The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients.
Transmembrane topology of glucose-6-phosphatase.
Transmembrane topology of human glucose 6-phosphate transporter.
Two new mutations in the glucose-6-phosphatase gene cause glycogen storage disease in Hungarian patients.
Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system.
Type Ib glycogenosis.
Type La glycogen storage disease with focal nodular hyperplasia in siblings.
Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene.
Unreliability of platelet glucose-6-phosphatase for the diagnosis of glycogen storage disease type Ia.
Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
[Biological and physiopathological aspects of hepatic glycogenoses]
[Carbohydrates in the treatment of glycogenoses]
[Clinical and molecular genetic analysis for a patient with glycogen storage disease ?a].
[CONTRIBUTION TO THE METABOLISM OF ALPHA-KETO ACIDS IN GLYCOGENOSIS WITH GLUCOSE-6-PHOSPHATASE INSUFFICIENCY.]
[Genetic heterogeneity and the diagnosis of hepatic glycogenoses]
[Glycogen storage disease type I with normal in vitro activity of glucose-6-phosphatase (author's transl)]
[Glycogenoses type 1b and 1c]
[Hepatic glycogenoses. Correlations between the clinical and biochemical characteristics and the type of enzymatic deficiency: glucose-6-phosphatase, amylo-1-6-glucosidase, phosphorylase.]
[Hepatic glycogenoses. Introduction]
[Hepatic glycogenosis caused by glucose-6-phosphatase associated with a thrombopathy.]
[Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation]
[ON A SPECIAL FORM OF GIERKE'S GLYCOGENOSIS WITH INCREASED ALPHA-GLUCOSIDASE ACTIVITY IN THE LIVER AND COMPLETE LACK OF GLUCOSE-6-PHOSPHATASE.]
[The Fanconi-Bickel syndrome]
[Treatment of glycogen storage diseases]
Glycogen Storage Disease Type I
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
A new model for the membrane topology of glucose-6-phosphatase: the enzyme involved in von Gierke disease.
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a.
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
AAV-MEDIATED CORRECTION OF A CANINE MODEL OF GLYCOGEN STORAGE DISEASE TYPE IA.
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
An algorithmic approach to diagnosis of hypoglycemia.
Analysis of the albino-locus region of the mouse: IV. Characterization of 34 deficiencies.
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
Candidate polymorphisms and severe malaria in a malian population.
Cell death and stress signaling in glycogen storage disease type I.
Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines.
Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
Continuous glucose monitoring in children with glycogen storage disease type I.
Defect of platelet function associated with chronic hypoglycaemia.
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.
Disorders associated with purine and pyrimidine metabolism.
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Emerging therapies for glycogen storage disease type I.
FDG PET/CT in Type I Glycogen Storage Disease.
Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report.
Glucose-6-phosphatase activity in liver and blood platelets of two patients with glycogen storage disease type I.
Glucose-6-phosphatase deficiency and hyperlipaemia.
Glucose-6-phosphatase deficiency caused by radiation-induced alleles at the albino locus in the mouse.
Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.
Glucose-6-phosphatase deficiency.
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies.
Glycogen storage disease type 1a in three siblings with the G270V mutation.
Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells.
Glycogenosis type IB: possible membrane transport defect.
Hepatic adenomata with type 1 glycogen storage disease.
Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome.
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.
Hepatocyte nuclear factor 1alpha is an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids.
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Heteroduplex analysis: a useful screening method for glycogen storage disease type Ia.
Human microsomal glucose-6-phosphatase system.
Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
Hypovitaminosis D in glycogen storage disease type I.
Impaired platelet function in glucose-6-phosphatase deficiency.
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.
Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Intestinal function in glycogen storage disease type I.
Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
Ischemic stroke in an adult with glycogen storage disease type I.
Learning from claims: hyperbilirubinaemia and kernicterus.
Lipid storage myopathy in von Gierke's disease: a case report.
Liver transplantation in glycogen storage disease type I.
Metabolic control of von Gierke disease (glycogen storage disease type Ia) in pregnancy: maintenance of euglycemia with cornstarch.
Molecular Genetics of Type 1 Glycogen Storage Diseases.
Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Platelet glucose-6-phosphatase activity in patients with von Gierke's disease and their parents.
Preemptive liver-kidney transplantation in von Gierke disease: a case report.
Preliminary studies of liver glucose-6-phosphatase in von Gierke's disease.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Renal complications in glycogen storage disease type I.
Renal tranplantation in type 1 glycogenosis. Failure to improve glucose metabolism.
Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings.
STUDIES IN GLYCOGEN STORAGE DISEASES. I. INTESTINAL GLUCOSE-6-PHOSPHATASE ACTIVITY IN PATIENTS WITH VON GIERKE'S DISEASE AND THEIR PARENTS.
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
The diagnostic value of thrombocytic glucose-6-phosphatase in patients with von Gierke's disease and its heterozygotes.
The glucose-6-phosphatase system in human development.
The lactate concentration of the urine, a parameter for the adequacy of dietary treatment of patients with glucose-6-phosphatase deficiency.
The molecular basis of the type 1 glycogen storage diseases.
The molecular basis of type 1 glycogen storage diseases.
The prenatal determination of glucose-6-phosphatase activity by fetal liver biopsy.
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency.
Two new mutations in the glucose-6-phosphatase gene cause glycogen storage disease in Hungarian patients.
Type La glycogen storage disease with focal nodular hyperplasia in siblings.
Urate production in heterozygotes for glucose-6-phosphatase deficiency.
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
[A case of Gierke's disease]
[Glycogen storage disease type I with normal in vitro activity of glucose-6-phosphatase (author's transl)]
[Late manifestation of glycogenosis I in early adulthood]
[Late manifestations of glycogenosis 1 in early adulthood]
[Treatment of glycogen storage diseases]
Glycogen Storage Disease Type III
A case of limit dextrinosis (Cori's disease) with lowered activity of glucose-6-phosphatase.
Glycosuria
The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver.
Gout
A Multidisciplinary Approach for Tophi Wounds Caused by Glycogen Storage Disease Type 1a: A Rare Case.
Clinical and enzymological studies in a child with type I glycogen storage disease associated with partial deficiency of hepatic glucose-6-phosphatase.
Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
Granuloma
Susceptibility of desert sheep to infection with Schistosoma mansoni of Northern Sudan.
Heart Defects, Congenital
G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia.
G6PC3 mutations cause non-syndromic severe congenital neutropenia.
Hepatitis
Changes in catalase and glucose-6-phosphatase distribution patterns within oval cell compartment as possible differentiation markers during viral hepatocarcinogenesis in woodchucks.
Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
Serum glucose-6-phosphatase activity in acute hepatitis.
[Glucose-6-phosphatase in the liver of subject with acute viral hepatitis and cirrhosis.]
[Studies on the behavior of the serum glucose-6-phosphatase activity in acute hepatitis]
Hepatitis B
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Hepatitis, Chronic
[Features of the effect of bemethyl on glycogen metabolism in hepatocytes of pathological changed human liver]
Hepatolenticular Degeneration
Metabolic disorders in children.
Hepatomegaly
A 20-year follow-up of a male patient with type Ia glycogen storage disease.
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats.
Diagnosis of type 1a and type 1c glycogen storage diseases in adults.
Glucose-6-phosphatase deficiency.
Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Problems in the congenital lactic acidoses.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
The molecular basis of type 1 glycogen storage diseases.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
[Neutropenia in glycogenesis I B]
Herpes Zoster
The human adrenal microsomal glucose-6-phosphatase system.
Hodgkin Disease
Glucose-6-phosphatase activity of Reed-Sternberg and Hodgkin cells.
Huntington Disease
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia.
Hypercholesterolemia
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
[Effect of whole-body vibration on glucose concentration and gluconeogenesis enzyme activity in the blood and tissues of rabbits with experimental hypercholesterolemia]
Hyperglycemia
A high-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice.
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice.
Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds.
Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica.
Biochemical evidence on the potential role of organophosphates in hepatic glucose metabolism toward insulin resistance through inflammatory signaling and free radical pathways.
Chronic effects of clozapine administration on insulin resistance in rats: evidence for adverse metabolic effects.
Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Common variants at ten genomic loci influence hemoglobin A1C levels via glycemic and non-glycemic pathways.
Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice.
Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase.
Effect of diabetes on the rat hepatic glucose-6-phosphatase system in endoplasmic reticulum subfractions.
Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
Effects of tephrosia purpurea aqueous seed extract on blood glucose and antioxidant enzyme activities in streptozotocin induced diabetic rats.
Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia.
Evaluation of the antithyroid, antioxidative and antihyperglycemic activity of scopoletin from Aegle marmelos leaves in hyperthyroid rats.
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.
G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase.
Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats.
Glucose utilization and anti-oxidative mechanisms of the aqueous hunteria umbellata seed extract in alloxan-induced diabetic rats.
Hepatic ERK activity plays a role in energy metabolism.
Hyperglycemia contributes to impaired insulin response in GK rat islets.
Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
Influence of glibenclamide on the efficacy of calcium trisodium pentetat as an antidote for cadmium toxicity.
Instant White Rice with Pigmented Giant Embryonic Rice Improves Glucose Metabolism and Inhibits Oxidative Stress in High-Fat Diet-Fed Mice.
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Lack of significant long-term effect of dietary carbohydrates on hepatic glucose-6-phosphatase expression in rainbow trout (Oncorhynchus mykiss).
Liver-specific iNOS expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.
Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.
Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
Metabolism and fatty acid profile in fat and lean rainbow trout lines fed with vegetable oil: effect of carbohydrates.
MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice.
Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions.
Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice.
Salidroside improves glucose homeostasis in obese mice by repressing inflammation in white adipose tissues and improving leptin sensitivity in hypothalamus.
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
Specific reduction of G6PT may contribute to downregulation of hepatic 11?-HSD1 in diabetic mice.
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance.
The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase.
The Impact of Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on Glycemia.
The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.
Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr(P1195L/+) mice fed high-fat-diet.
Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats.
[The effect of prenatal hyper- and hypoglycemia on liver mitochondrial function and carbohydrate metabolism in rat pups]
Hyperhomocysteinemia
[Effect of homocysteine on gluconeogenesis in mice].
Hyperinsulinism
Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal substrates, hormones, and hepatic enzymes.
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
Derangement in hepatic enzymes caused by sucrose-drinking and its implication for the development of hyperglycemia in female Wistar fatty rats.
Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice.
Hepatic insulin resistance induced by chronic hindlimb ischemia.
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs.
Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis.
Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo.
Surgical removal of visceral fat reverses hepatic insulin resistance.
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance.
Vanillic acid mitigates the impairments in glucose metabolism in HepG2 cells through BAD-GK interaction during hyperinsulinemia.
Hyperlactatemia
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Hyperlipidemias
A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice.
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
Hypovitaminosis D in glycogen storage disease type I.
Placental permeability and energy metabolism enzymes in fetuses of lipemic rats.
Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
The molecular basis of type 1 glycogen storage diseases.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
[Neutropenia in glycogenesis I B]
Hypertension
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
[Endocrine-metabolic relations in rats with genetic arterial hypertension]
[Fundamental and applied studies on transport and metabolism of electrolytes and glucose--aim to contact with molecular biology]
Hypertension, Pulmonary
Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
Hyperthyroidism
Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats.
Evaluation of the antithyroid, antioxidative and antihyperglycemic activity of scopoletin from Aegle marmelos leaves in hyperthyroid rats.
Glucose turnover in hyperthyroid patients with normal glucose tolerance.
Response of hepatic glucokinase and glucose-6-phosphatase activities in juvenile and adult hyperthyroid mice.
Hypertriglyceridemia
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Hypoglycemia
A central role of RLIP76 in regulation of glycemic control.
A detailed characterization of the adult mouse model of glycogen storage disease Ia.
A hypothesis linking hypoglycemia, hyperuricemia, lactic acidemia, and reduced gluconeogenesis in alcoholics to inactivation of glucose-6-phosphatase activity by acetaldehyde.
AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Activation of liver G-6-Pase in response to insulin-induced hypoglycemia or epinephrine infusion in the rat.
Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Alterations in glucose homeostasis in a murine model of chagas disease.
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia.
Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep.
Combined deficiency of glucose-6-phosphatase and fructose-1, 6-diphosphatase. Studies of glucagon secretion and fuel utilization.
Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency.
Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis.
Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
Effect of anabolic steroid, methylandrostenediol, on the intravenous insulin hypoglycemia and on liver glucose-6-phosphatase activity in male rats.
Effect of gamma-hexachlorocyclohexane (lindane) on carp (Cyprinus carpio). II. Effects of chronic intoxication on blood, liver enzymes, and muscle plasmic membrane.
Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease.
Efficacy of Helper-dependent Adenovirus Vector-mediated Gene Therapy in Murine Glycogen Storage Disease Type Ia.
Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles.
Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Hyperuricemia in glycogen storage disease type I. Contributions by hypoglycemia and hyperglucagonemia to increased urate production.
Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene.
Hypovitaminosis D in glycogen storage disease type I.
In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.
Induction in utero of hepatic glucose-6-phosphatase by fetal hypoinsulinemia.
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Liver Glucokinase(A456V) Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase.
Liver glucose-6-phosphatase activity and blood fatty acid level in rats with insulin-induced hypoglycemia.
Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
Long-Term Effects of Prenatal Severe Hypoxia on Central and Peripheral Components of the Glucocorticoid System in Rats.
Long-Term Efficacy Following Readministration of an Adeno-Associated Virus Vector in Dogs with Glycogen Storage Disease Type Ia.
Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.
Rapid ethanol elimination in patients with type I glycogen storage disease is an adaptive change resulting from recurrent hypoglycemia.
Regulation of liver metabolism by the endosomal GTPase Rab5.
Renal and biochemical changes produced in broilers by high-protein, high-calcium, urea-containing, and vitamin-A-deficient diets.
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report.
Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia.
The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through ROR? and SRC-2 coactivator transcriptional activity.
The molecular basis of type 1 glycogen storage diseases.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
[Neutropenia in glycogenesis I B]
[The effect of prenatal hyper- and hypoglycemia on liver mitochondrial function and carbohydrate metabolism in rat pups]
Hyponatremia
Effect of gamma-hexachlorocyclohexane (lindane) on carp (Cyprinus carpio). II. Effects of chronic intoxication on blood, liver enzymes, and muscle plasmic membrane.
Hypophosphatemia
Up-regulation of liver glucose-6-phosphatase in x-linked hypophosphatemic mice.
Hypotension
Alterations in hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and glucose-6-phosphatase gene expression after hemorrhagic hypotension and resuscitation.
Regulation of liver and kidney glucose-6-phosphatase gene expression in hemorrhage and resuscitation.
hypoxanthine phosphoribosyltransferase deficiency
Disorders associated with purine and pyrimidine metabolism.
Infections
Biochemical studies in the vole, Microtus montanus. II. The effects of a Trypanosoma brucei gambiense infection on the diurnal variation of hepatic glucose-6-phosphatase and liver glycogen.
Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a).
Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.
Effect of praziquantel on some aspects of carbohydrate metabolism in mice infected with Schistosoma mansoni.
Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection.
Isolation and partial characterization of plasma membranes from the livers of control and Streptococcus pneumoniae-infected rats.
Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders.
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
Inflammatory Bowel Diseases
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Insulin Resistance
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice.
Aging is associated with increased TRB3, ER stress, and hepatic glucose production in the liver of rats.
Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
Asthma alleviates obesity in males through regulating metabolism and energy expenditure.
Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet.
Beneficial effects of Aronia melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats.
Carbohydrate intolerance associated with reduced hepatic glucose phosphorylating and releasing enzyme activities and peripheral insulin resistance in alcoholics with liver cirrhosis.
Central administration of vaspin inhibits glucose production and augments hepatic insulin signaling in high-fat-diet-fed rat.
Chronic effects of clozapine administration on insulin resistance in rats: evidence for adverse metabolic effects.
Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment.
Deficiency in Interferon-{gamma} Results in Reduced Body Weight and Better Glucose Tolerance in Mice.
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
DHEA-induced modulation of renal gluconeogenesis, insulin sensitivity and plasma lipid profile in the control- and dexamethasone-treated rabbits. Metabolic studies.
Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation.
Effect of trivalent chromium on erythropoietin production and the prevention of insulin resistance in HepG2 cells.
Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice.
Effects of coffee on type 2 diabetes mellitus.
Effects of fasting and refeeding on the activity of hepatic glucose-6-phosphatase in rats.
Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Effects of the Combined Extracts of Grape Pomace and Omija Fruit on Hyperglycemia and Adiposity in Type 2 Diabetic Mice.
Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice.
Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats.
G6PC2: A Negative Regulator of Basal Glucose-Stimulated Insulin Secretion.
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Hawthorn polyphenols, D-chiro-inositol, and epigallocatechin gallate exert a synergistic hypoglycemic effect.
Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance.
Hepatic insulin resistance induced by chronic hindlimb ischemia.
Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1? and dephosphorylation of FoxO1.
High-Efficacy ?,?-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats.
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms.
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.
Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats.
Insulin resistance and the transcription of the glucose-6-phosphatase gene in newborn dogs.
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Jiaogulan tea (Gpostemma pentaphyllum) potentiates the antidiabetic effect of white tea via the AMPK and PI3K pathways in C57BL/6 mice.
Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.
Mibefradil reduces hepatic glucose output in HepG2 cells via Ca2+/calmodulin-dependent protein kinase II-dependent Akt/forkhead box O1signaling.
MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Mitigating Perspectives of Asiatic acid in the Renal derangements of Streptozotocin-Nicotinamide induced Diabetic Rats.
Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet.
Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence.
Renal Denervation Reverses Hepatic Insulin Resistance Induced by High-Fat Diet.
SIK1 Regulates CRTC2-Mediated Gluconeogenesis Signaling Pathway in Human and Mouse Liver Cells.
Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Small intestinal metabolism is central to whole-body insulin resistance.
Specific reduction of G6PT may contribute to downregulation of hepatic 11?-HSD1 in diabetic mice.
Surgical removal of visceral fat reverses hepatic insulin resistance.
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.
Transcription factor TIP27 regulates glucose homeostasis and insulin sensitivity in a PI3-kinase/Akt-dependent manner in mice.
Up-regulation of liver glucose-6-phosphatase in rats fed with a P(i)-deficient diet.
Zingiber mioga reduces weight gain, insulin resistance and hepatic gluconeogenesis in diet-induced obese mice.
[Effect of intrauterine growth retardation on gluconeogenic enzymes in rat liver].
[Increased expression of gluconeogenic enzymes in the liver of IUGR rats and subsequent insulin resistance]
Insulinoma
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines.
Expression of constructs between the glucose-6-phosphatase promoter and a reporter gene in an insulinoma cell line: regulation by glucose, dibutyryl cAMP and dexamethasone.
Glucose induces glucose 6-phosphatase hydrolytic subunit gene transcription in an insulinoma cell line (INS-1).
Glucose-6-phosphatase in the insulin secreting cell line INS-1.
Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein.
Leptospirosis
Alterations in specific activity of glucose-6-phosphatase in laboratory rats after leptospiral exposure followed by triiodothyronine administration.
Leukemia
Liver glucose-6-phosphatase and carbohydrate metabolism in childhood leukemia.
REDUCED LIVER GLUCOSE-6-PHOSPHATASE IN HUMAN LEUKEMIA.
Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.
[Glucose-6-phosphatase activity in experimental tumors and leucocytes of human leukemias.]
Leukodystrophy, Globoid Cell
Metabolic disorders in children.
Leukoplakia
[Submicroscopic localization of glucose-6-phosphatase in leukoplakia and carcinoma of the oral cavity]
Liver Cirrhosis
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Prevention of CCL4-induced liver cirrhosis by silymarin.
Restoration of the glycogen-forming function of hepatocytes in rats with liver cirrhosis is facilitated by a high-carbohydrate diet.
[Rehabilitation of the hepatocyte glycogen-forming function in the rat cirrhotic liver due to carbohydrate rich diet]
[The glycogen-forming function of the hepatocytes during the regeneration of the cirrhotic rat liver after a partial hepatectomy]
Liver Diseases
Asymptomatic decreased activities of hepatic glucose-6-phosphatase and glycogen phosphorylase in a number of children with chronic liver disease.
Pathological occurrence of glucose-6-phosphatase in serum in liver diseases.
[Studies on serum glucose-6-phosphatase activity of the liver in children. 4. On hepatic glucose-6-phosphatase activity level in congenital bile-duct atresia and other liver diseases in children.]
Liver Failure, Acute
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Liver Neoplasms
Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital.
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Liver Neoplasms, Experimental
Correlation between growth rate and cytochemistry in Morris hepatomas.
Lymphoma
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Alterations in total iron, zinc, and calcium levels and their influence on the hepatic activities of gamma-glutamyl transferase and glucose-6-phosphatase in the host bearing transplantable murine lymphoma.
Lymphoma, B-Cell
Trace Mineral Overload Induced Hepatic Oxidative Damage and Apoptosis in Pigs with Long-Term High-Level Dietary Mineral Exposure.
Lymphopenia
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Magnesium Deficiency
Hepatic gluconeogenic enzymes, plasma insulin and glucagon response to magnesium deficiency and fasting.
Malaria
A patient with acute liver failure and extreme hypoglycaemia with lactic acidosis who was not in a coma: causes and consequences of lactate-protected hypoglycaemia.
Malnutrition
Evidence for liver energy metabolism programming in offspring subjected to intrauterine undernutrition during midgestation.
Melanoma
Cathepsin B: association with plasma membrane in metastatic tumors.
Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
Metabolic Diseases
Glucose-6-phosphatase deficiency.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia.
Metabolic Syndrome
Association analysis of genetic variants with metabolic syndrome components in the Moroccan population.
Methemoglobinemia
Delayed Diagnosis in Army Ranger Postdeployment Primaquine-Induced Methemoglobinemia.
Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency: case report and literature review.
Myeloproliferative Disorders
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia.
Neoplasm Metastasis
Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.
Neoplasms
A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a.
Alteration by phenobarbital of membrane-associated enzymes including gamma glutamyl transpeptidase in mouse liver neoplasms.
Alterations in total iron, zinc, and calcium levels and their influence on the hepatic activities of gamma-glutamyl transferase and glucose-6-phosphatase in the host bearing transplantable murine lymphoma.
Altered oxidative stress and carbohydrate metabolism in canine mammary tumors.
Anti-Diabetic Effect of Trigonelline and Nicotinic Acid, on KK-A(y) Mice.
Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice.
Biochemical evidence on the potential role of organophosphates in hepatic glucose metabolism toward insulin resistance through inflammatory signaling and free radical pathways.
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Changes in the cellular phenotype and extracellular matrix during progression of estrogen-induced mesenchymal kidney tumors in Syrian hamsters.
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines.
Comparison of Ehrlich ascites tumour and mouse liver cells by analytical subcellular fractionation combined with a sensitive computational method for data analysis.
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Detection of a novel, primate-specific 'kill switch' tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53.
Detection of a novel, primate-specific ‘kill switch’ tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53
Development of liver tumors in transforming growth factor alpha transgenic mice.
Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Effect of glutathione and N-acetylcysteine on hepatocellular modifications induced by 2-acetylaminofluorene.
Effect of partial hepatectomy on tumor incidence and metabolism of mice fed thioacetamide.
Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma.
Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat.
Effects of dietary energy on antioxidant capacity, glucose-lipid metabolism and meat fatty acid profile of Holstein bulls at different ages.
Effects of female sex steroids on concanavalin A-mediated agglutination of hepatocytes from nonregenerating and regenerating rat liver and hepatic tumor marker enzymes.
Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.
Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Food Shortage Causes Differential Effects on Body Composition and Tissue-Specific Gene Expression in Salmon Modified for Increased Growth Hormone Production.
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells.
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase.
Glucose phosphatase in benign and malignant tumours of the prostate. (Preliminary communication).
Glucose-6-phosphatase activity in primary rat liver tumors induced by high doses of 4-dimethylaminoazo-benzene.
Glucose-6-phosphatase and phosphorylase activities in mice bearing corticotropin-secreting tumors.
Glucose-6-phosphatase as a marker for tumors of liver and kidney origin.
Glucose-6-phosphatase Expression-Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models.
Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
GLUCOSE-6-PHOSPHATASE: REEXAMINATION OF THE RNA-INDUCED ACTIVITY IN MOUSE ASCITES TUMOR CELLS.
Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met.
Histochemical characteristics of spontaneous and chemically induced hepatocellular neoplasms in mice and the development of neoplasms with gamma-glutamyl transpeptidase activity during phenobarbital exposure.
Histochemistry of liver tumors induced by diethylnitrosamine and differential sex susceptibility to carcinogenesis in Oryzias latipes.
Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.
Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose.
Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels.
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.
Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns.
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Morphologic and cytochemical properties of mouse liver neoplasms induced by diethylnitrosamine and promoted by 4,4'-dichlorodiphenyltrichloroethane, chlordane, or heptachlor.
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice.
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
Prospects for glycerol-rescued hypoglycemia as a cancer therapy.
Quantitative evaluation of insulin resistance markers in Pakistani patients suffering from HCV-associated type 2 diabetes mellitus.
Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney.
Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the rhesus monkey.
Serum and hepatic enzyme activity in rats treated with diethylnitrosamine.
Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?
The hepatic glucose-6-phosphatase system in Ehrlich-ascites-tumour-bearing mice.
The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models.
The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells.
Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
Tumor Formation in Liver of Conditional {beta}-Catenin-Deficient Mice Exposed to a Diethylnitrosamine / Phenobarbital Tumor Promotion Regimen.
Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.
Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro.
Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.
Ultracytochemical localization of glucose-6-phosphatase in Chang rat hepatoma in vivo and in vitro.
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.
von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
[A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer]
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
[Changes of hepatic glycogen, lactic acid, glucose-6-phosphatase activity and succinate dehydrogenase in the sourse of tumor development under the influence of B thymus extract]
[Definition and classification of hyperuricemia]
[FDG-PET in hepatocellular carcinoma. Based on one case]
[Fibrolamellar liver carcinoma]
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray]
[Glucose-6-phosphatase activity in experimental tumors and leucocytes of human leukemias.]
[Glucose-6-phosphatase and aldolase in primary liver tumors induced by diethylnitrosamine]
[Lipid dependence of nuclear glucose-6-phosphatase in the tumor growth process and the change in its nature after the irradiation of tumor carriers]
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
[Properties and isoenzyme contents of glucose-6-phosphatase of normal and tumor cell microsomes]
[Subcellular particles in tumors. I. Intracellular distribution of cytochrome oxidase, glucose-6-phosphatase, catalase, and several acid hydrolases in a transplantable chemically induced heatoma (hepatoma HW)]
[The role of arecoline on hepatic insulin resistance in type 2 diabetes rats].
[Various enzymes of isolated nuclear membranes and cell nuclei of the liver and hepatoma 27 of rats]
Neuroblastoma
Glucose-6-phosphatase-? participates in dopaminergic differentiation.
Inhibition of Glycogen Synthase Kinase-3? by Falcarindiol Isolated from Japanese Parsley (Oenanthe javanica).
[Rapid simultaneous isolation of microsomes and plasma membranes from neuroblastoma C 1300 N 18 cells]
Neuroendocrine Tumors
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Neutropenia
A case of syndromic neutropenia and mutation in G6PC3.
A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.
A novel G6PC3 gene mutation in severe congenital neutropenia: pancytopenia and variable bone marrow phenotype can also be part of this syndrome.
A Severe Congenital Neutropenia Type 4 Case (G6PC3 Mutation) Presented With Large Platelets in the Peripheral Smear.
A syndrome with congenital neutropenia and mutations in G6PC3.
Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype.
Amyloidosis in a Patient With Congenital Neutropenia Because of G6PC3 Deficiency.
Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents.
Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: Novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia.
Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia.
G6PC3 mutations cause non-syndromic severe congenital neutropenia.
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells.
NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation.
Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Obesity
Effects of G6pc2 deletion on body weight and cholesterol in mice.
Glucose-6-phosphatase activity in the hypothalamus of the ob/ob mouse.
Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice.
[STUDY RELATIVE EXPRESSION OF GENES THAT CONTROL GLUCOSE METABOLISM IN THE LIVER IN MICE WITH DEVELOPMENT OF MELANOCORTIN OBESITY].
Obesity, Abdominal
Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver.
Ovarian Neoplasms
Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer.
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.
pantoate-beta-alanine ligase (amp-forming) deficiency
Disorders associated with purine and pyrimidine metabolism.
Parasitic Diseases
Activity of some hydrolytic enzymes in tissue homogenates and haemolymph of fresh water snails, intermediate hosts in schistosomiasis.
Persistent Infection
Changes in catalase and glucose-6-phosphatase distribution patterns within oval cell compartment as possible differentiation markers during viral hepatocarcinogenesis in woodchucks.
Plague
[Activity of alpha-amylase and glucose-6-phosphatase in the liver and blood sugar level in animals infected with plague]
Polyuria
The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver.
[Fundamental and applied studies on transport and metabolism of electrolytes and glucose--aim to contact with molecular biology]
pullulanase deficiency
The molecular background of glycogen metabolism disorders.
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Renal Insufficiency
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Iotaa.
Reperfusion Injury
Effect of ischemia-reperfusion on the heterogeneous lobular distribution pattern of glycogen content and glucose-6-phosphatase activity in human liver allograft.
Histoenzymatic study of human renal tissue preservation: I--Proximal tubular glucose-6-phosphatase is correlated with transplant evolution.
Respiratory Distress Syndrome
Early detection of metabolic abnormalities in preterm infants impaired by disorders of blood glucose concentrations.
Reye Syndrome
Reye's syndrome: preservation of mitochondrial enzymes in brain and muscle compared with liver.
Rhabdomyosarcoma
Construction and characterization of a conditionally active construct of the insulin-regulated forkhead transcription factor FKHR.
Rickets
[Liver & kidney glucose-6-phosphatase in experimental rickets in rat & the effect of vitamin D.]
Sarcoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.
Sarcoma, Avian
Metabolism of 2-[18F]fluoro-2-deoxyglucose in tumor-bearing rats: chromatographic and enzymatic studies.
Schistosomiasis
Activity of some hydrolytic enzymes in tissue homogenates and haemolymph of fresh water snails, intermediate hosts in schistosomiasis.
Schistosomiasis mansoni
Effect of praziquantel on some aspects of carbohydrate metabolism in mice infected with Schistosoma mansoni.
Ultrastructural cytochemistry of glucose 6-phosphatase in experimental prepatent Schistosomiasis mansoni.
Sepsis
Alterations in glucose-6-phosphatase gene expression in sepsis.
Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat.
Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity.
Siderosis
[Induction, characterization and isolation of preneoplastic hepatocytes following combined treatment with 2-acetaminofluorene and ferric nitrilotriacetate]
Silicosis
[Biochemical investigations of the silicosis problem; enzyme inhibition by silicic acid in the case of microsomal glucose-6-phosphatase.]
Skin Abnormalities
[Clinical and biochemical alterations in rats treated with high doses of vitamin A]
Sleep Deprivation
Rapid eye movement sleep-deprivation-induced changes in glucose metabolic enzymes in rat brain.
Starvation
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.
A novel amino acid signaling process governs glucose-6-phosphatase transcription.
Abnormal expression of glucose-6-phosphatase in preterm infants.
Age-dependent glycolysis and gluconeogenesis enzyme activities in starved-refed rats.
Comparison between starvation and consumption of a high protein diet: plasma insulin and glucagon and hepatic activities of gluconeogenic enzymes during the first 24 hours.
Distribution along the rat nephron of three enzymes of gluconeogenesis in acidosis and starvation.
Effect of starvation on fructose diphosphatase, glucose-6-phosphatase and phosphoglucomutase activities in organs of Pseudemys (Chrysemys) scripta elegans.
Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat.
Fuel utilization in colonocytes of the rat.
Glucose phosphorylation and dephosphorylation in chicken liver.
Glucose-6-phosphatase mRNA levels in kidney isolated tubule suspensions are increased by dexamethasone and decreased by insulin.
Hypoglycemic effects of Coccinia indica: inhibition of key gluconeogenic enzyme, glucose-6-phosphatase.
In situ kinetic parameters of glucose-6-phosphatase in the rat liver lobulus.
Molecular cloning of hepatic glucose-6-phosphatase catalytic subunit from gilthead sea bream (Sparus aurata): response of its mRNA levels and glucokinase expression to refeeding and diet composition.
Nutritional regulation of glucose-6-phosphatase gene expression in liver of the gilthead sea bream (Sparus aurata).
Quantitative aspects of relationship between glucose 6-phosphate transport and hydrolysis for liver microsomal glucose-6-phosphatase system. Selective thermal inactivation of catalytic component in situ at acid pH.
Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase.
Role of small leucine zipper protein in hepatic gluconeogenesis and metabolic disorder.
Sex-specific regionality of liver metabolism during starvation; with special reference to the heterogeneity of the lobular periphery.
Significance of the increase in glucose 6-phosphatase activity in skeletal muscle cells of the mouse by starvation.
The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
The glucose-6-phosphatase system.
The regulation of serine dehydratase and glucose-6-phosphatase in hyperplastic nodules of rat liver during diethylnitrosamine and N-2-fluorenylacetamide feeding.
[Enzyme activity of gluconeogenesis in dietary thiamine deficiency]
[Late manifestations of glycogenosis 1 in early adulthood]
Stomach Neoplasms
Ultrastructural cytochemical study of enzymes expressed by signet ring cells in gastric cancer.
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
Stroke
Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia.
Thrombocytopenia
Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation.
Thyrotoxicosis
Role of a gitogenin-type steroidal saponin (3-O-?-d-glucopyranosyl (1?2)-?-d-glucopyranosyl (1?4)-?-d-galactopyranoside-25R,5?-spirostane-2?,3?-diol), isolated from the leaves of Malvastrum coromandelianum in regulating thyrotoxicosis in rats.
[Certain indicators of carbohydrate metabolism and functional state of the islands of Langerhans in thyrotoxicosis]
[Serum glucose-6-phosphatase activity in thyrotoxicosis patients both fasting and following a sugar load]
Tuberculosis
Glucose-6-phosphatase activity in experimental tuberculosis and following isoniazid treatment.
Urinary Bladder Neoplasms
[Histochemical investigations on human bladder cancer (author's transl)]
Urogenital Abnormalities
A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.
Novel G6PC3 Mutations in patients with Congenital Neutropenia: Case reports and Review of the Literature.
Virus Diseases
[Metabolic aspects of hepatic tissue in MHV-3 virus infections of the mouse. III. Glucose-6-phosphatase activity.]
Vitamin B 12 Deficiency
[Glucose-6-phosphatase activity in the rat liver in vitamin B12 deficiency.]
Vitamin E Deficiency
Cellular membranes and membrane-bound enzymes in vitamin E deficiency. A histochemical, cytochemical, biochemical, and morphologic study of the liver of the Pekin duckling.
[protein-pii] uridylyltransferase deficiency
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats.